Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy-Reference-Cited by-同舟云学术

Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy

Published:2020-07-01 Issue:7 Volume:24 Page:729-731
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Kadota J. L.¹,Katamba A.²,Musinguzi A.³,Welishe F.³,Nabunje J.³,Ssemata J. L.³,Berger C. A.¹,Kamya M. R.⁴,Namusobya J.⁵,Semitala F. C.⁶,Cattamanchi A.⁷,Dowdy D. W.⁸

Affiliation:

1. Division of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA

2. Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda, Department of Medicine, Makerere University, Kampala, Uganda

3. Infectious Diseases Research Collaboration, Kampala, Uganda

4. Department of Medicine, Makerere University, Kampala, Uganda, Infectious Diseases Research Collaboration, Kampala, Uganda

5. University Research Company, Center for Human Services, Department of Defense HIV/AIDS Prevention Program (URC-DHAPP), Kampala, Uganda

6. Department of Medicine, Makerere University, Kampala, Uganda, Infectious Diseases Research Collaboration, Kampala, Uganda, Makerere University Joint AIDS Program, Kampala, Uganda

7. Division of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA, Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda

8. Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, , Email: axk95@case.edu

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial;PLOS Medicine;2024-02-20

2. Efficacy and Safety of Different Drug Regimens for Tuberculosis Preventive Treatment: A Systematic Review and Meta-Analysis;Cureus;2023-04-26

3. Integrating interferon-gamma release assay testing into provision of tuberculosis preventive therapy is feasible in a tuberculosis high burden resource-limited setting: A mixed methods study;PLOS Global Public Health;2022-07-06

4. Completion of isoniazid–rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness–implementation randomized trial;PLOS Medicine;2021-12-16

5. Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives;Implementation Science Communications;2021-06-30